© 2022 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
December 28, 2021
Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
August 17, 2021
Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.